Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin.
about
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathyImmunosuppressant and immunomodulatory treatments for multifocal motor neuropathyImmunosuppressant and immunomodulatory treatments for multifocal motor neuropathyCorticosteroids for chronic inflammatory demyelinating polyradiculoneuropathyImmunosuppressant and immunomodulatory treatments for multifocal motor neuropathyMimics and chameleons in motor neurone diseaseSystematic reviews of treatment for inflammatory demyelinating neuropathyRapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodiesDifferentiating lower motor neuron syndromesMultifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variantsTreatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy: a pilot study.Long term follow up of multifocal motor neuropathy with conduction block under treatment.Diagnosis of motor neuropathy.Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination patternPure sensory chronic inflammatory polyneuropathy: rapid deterioration after steroid treatment.A variant of multifocal motor neuropathy with acute, generalised presentation and persistent conduction blocks.The effect of treatment upon temporal dispersion in IvIg responsive multifocal motor neuropathyA practical definition of conduction block in IvIg responsive multifocal motor neuropathyChronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.Predicting treatment response in chronic, acquired demyelinating neuropathies.Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: treatment update.The Importance of Rare Subtypes in Diagnosis and Treatment of Peripheral Neuropathy: A Review.Evidence-based treatment of chronic immune-mediated neuropathies.Treatment of chronic inflammatory demyelinating polyneuropathy: from molecular bases to practical considerations.Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatmentTreatment in inflammatory neuropathies.Immunotherapy of multifocal motor neuropathy.Multifocal motor neuropathy: current therapies and novel strategies.Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approach.Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy.Steroids for chronic inflammatory demyelinating polyradiculoneuropathy: evidence base and clinical practice.The current place of high-dose immunoglobulins in the treatment of neuromuscular disorders.Chronic immune-related demyelinating neuropathies.Treatment of inflammatory neuropathy.A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy.Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.CIDP and other inflammatory neuropathies in diabetes - diagnosis and management.Comparing treatment options for chronic inflammatory neuropathies and choosing the right treatment plan.
P2860
Q24186751-32F49FD2-DA6C-4528-A73F-2EBF954FAB0FQ24187418-CFE2DBEE-D70A-4FDF-8031-C298AADC04F2Q24200228-979021EB-B271-48E0-8442-454CF20F7157Q24201662-D257E862-483D-4654-B891-BEF8ACE66B0CQ24241391-B12F18A5-65A2-4D40-BB3E-7C38E3B45339Q24619538-E201726D-92EA-4AE4-A43E-A82A3F373FFAQ24676037-9CF99580-A257-4427-8596-087745619E37Q26864907-D794667B-D7E6-4F24-83B1-558CB1E74CBDQ28070092-ABB9C166-231C-4715-9617-86F80D4155F0Q28390264-3FE43D17-3E92-4DB6-BD99-CFBA8FDF19F6Q30397454-20CA8D3B-F53D-4E6C-B70A-297D4748D807Q33735708-84A83D0F-0E33-4AFD-B80B-0EC53C336CDAQ33735714-C87F9EAD-8470-4127-9201-3E655027F176Q34235867-8926D57D-3BBA-4491-B0A4-4C0C58943527Q35141051-12A59802-DEB2-4C70-8CA8-74B761DE98D5Q35177035-99F45EE6-0B77-45E7-BEEC-EB5F34534F91Q35471156-3EA1EC9B-6221-49E1-A045-258B7882FFE8Q35489630-C1AB4FA3-3FBF-475D-85A5-9E515EF4998CQ35489932-A4B6E926-010B-4415-815C-9627B2FCC60AQ36005389-CD526A36-BB2D-448C-B6CD-990E11E8C8A4Q36641529-6B241D69-0FC5-44B1-9DAE-458F4A201BBBQ37329516-82F5FB11-6B2B-4E62-8174-210DEC06B26CQ37381546-46108879-48C6-4006-9993-54BEF2448416Q37550515-3AAD110E-75DC-45E1-92BC-486F23A98F82Q37557375-4A4572BC-96E4-4471-ADA4-0A6101401F26Q37696931-4EF7A269-287C-470D-A470-46EA792209BFQ37733512-CB611EA7-26C0-43E0-B1D8-52630689125BQ37836898-32033F00-1B42-4909-AA36-E68A679FD64AQ38091664-538A3740-DBED-4208-AB27-099BA8C02B45Q38194642-6D6D31A1-C243-419E-935C-51D24FA72431Q38270717-6DE3CAD8-0266-49A9-9C4C-3B9C4C08D876Q38334722-D02436F1-DF8A-42F5-80ED-5C7D7EC74EE7Q38599369-C888CD5B-4DB5-47BB-AF22-FE3191661CB0Q40906180-6D415614-FEF3-47F2-9013-E92825664051Q40939580-20CC22E9-DB3B-4D3E-86A0-582B117CA949Q41589697-DE15B21E-CCC9-4170-836D-804A83846278Q42654125-ECD53601-7022-4E46-B200-08E3F1522983Q43708051-D34A118D-C64C-4FC4-B725-BDFD6DE70585Q47978955-ABC6AF2C-315A-4ECB-BEFE-0C6694B3702BQ48301410-A39F0187-5EAA-43FA-8756-5B6CD2C738E9
P2860
Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Pure motor demyelinating neuro ...... th intravenous immunoglobulin.
@en
type
label
Pure motor demyelinating neuro ...... th intravenous immunoglobulin.
@en
prefLabel
Pure motor demyelinating neuro ...... th intravenous immunoglobulin.
@en
P2093
P2860
P356
P1476
Pure motor demyelinating neuro ...... th intravenous immunoglobulin.
@en
P2093
Boniface SJ
P2860
P304
P356
10.1136/JNNP.57.7.778
P407
P577
1994-07-01T00:00:00Z